i ----mice, the mechanism for production of this GHBP appears to be via an alternate transcript, as there are two RNA transcripts for GHR found in rat liver (Baumbach et al. 1989) . However, in pigs and other species there is only one RNA transcript for GHR in liver , and it has been shown in cultured cells that the extracellular domain of the GHR can be released by proteolytic cleavage of the membrane-bound receptor (Trivedi & Daughaday, 1988) . Thus, there are two possible mechanisms for nutritional-hormonal effects on growth, first via the GHR, which will affect GH action, and second via the GHBP, which may alter the half-life of GH, or affect its availability for binding to the GHR. 
Insulin-like growth factors
The IGF (IGF-I and -11) are two polypeptide growth factors which are structurally related to proinsulin. They are made up of seventy (IGF-I) and sixty-seven (IGF-11) amino acids, with a molecular mass of 7-65 and 7-47 kDa respectively, and share about 60 % homology (for review, see Sussenbach et al. 1992) . They have been shown to stimulate cell proliferation and differentiation, and to inhibit cell death (for review, see Jones & Clemmons, 1995) . The IGF have also been shown to stimulate protein synthesis, amino (IGF-I), Pl-P4 (IGF-II)), Alternative promoter initiation sites. *, Alternative polyadenylation sites. Primary mRNA molecules are derived from the splice permutations between alternatively-used exons (---) , and from the invariant splices (-) between exons 3 and 4 for IGF-I, and between exons 1, 2 and 3, and 7, 8 and 9 for IGF-11. (Adapted from Gilmour, 1994 and Sussenbach et al. 1992.) acid and glucose uptake, and to inhibit protein degradation in skeletal muscle cells in culture (Harper et al. 1987; Roe et al. 1989 Roe et al. , 1995 . IGF-I has been shown to mediate many of the growth-promoting effects of GH, and is produced postnatally, mainly by the liver, under GH control and secreted into the circulation. However, it is now well established that most tissues are capable of producing IGF-I, which may then act in an autocrine or paracrine manner to promote tissue growth. Very few fetal tissues express IGF-I, presumably due to the very low levels of GHR expression, and, therefore, IGF-I is considered to be mainly a postnatal growth factor. The gene for IGF-I has been cloned in many species including pig (Weller et al. 1993) , and has been shown to span nearly 90 kb DNA, and to consist of six exons (Fig. l(A) ). The first two exons (1 and 2) represent alternative pro-peptide domains and 5'-untranslated regions, which have associated transcriptional promoters, and result in two classes of transcript (the exon 1 promoter gives rise to class 1 transcripts). Exons 3 and 4 encode for the mature IGF-I polypeptide, and are present, therefore, in all transcripts, whereas exons 5 and 6 give rise to alternative E-domains and 3'-untranslated regions, likely to be involved in the processing and progress through the cell (see Sussenbach et al. 1992; Gilmour, 1994) .
IGF-I1 is produced mainly in the fetus by a variety of tissues, and this high level of expression in the fetus has led to the suggestion that it is a fetal growth factor. The gene for IGF-I1 has been cloned in few species, with the only large farm animal apparently being the sheep (Li et al. 1993) . The gene contains nine exons (Fig. l(B) ), but this time the first six exons represent alternative 5'-untranslated regions and have four associated promoters. The first promoter (exons 1-3) is only active in the postnatal liver, whereas the other three promoters (exons 4, 5 and 6) are only active in the fetus. Exons 7, 8 and 9 encode for the IGF-I1 precursor, and exon 9 also gives rise to two alternative 3'-untranslated regions (see Sussenbach et al. 1992 ).
Insulin-like growth factor-binding proteins
The IGF, like GH, circulate in the blood and extracellular fluid bound to specific binding proteins, and, to date, there are known to be six distinct IGFBP (IGFBP-1-IGFBP-6). Five of these have been described in pigs (McCusker et al. 1985; . They differ in the factors which regulate them, and also in their relative affinities for the two IGF, with IGFBP-1, -3 and -4 having similar affinities for IGF-I and IGF-11, but IGFBP-2, -5 and -6 having a higher affinity for IGF-11. The predominant IGFBP in blood is IGFBP-3, which is associated with both the IGF and an acid-labile subunit (ALS) to form a 150kJIa complex; other IGFBP found in pig blood include IGFBP-1, -2 and -4 Dauncey et al. 1993) . Unlike many hormones, the IGF are not stored intracellularly, but are in fact synthesized and then released from the cell. It has been suggested, therefore, that the large 150kDa complex of IGF, ALS and IGFBP-3 may be a mechanism for storing the IGF and then transporting it to the site of action. The actual effects of the IGFBP on IGF activity remains unclear, with various IGFBP found to inhibit, enhance or have no effect on IGF activity in cultured cells, depending on conditions and relative times of addition of the IGFBP and IGF (for review, see Zapf, 1995) . The genes for all six IGFBP have been cloned, and the gene structures are at varying stages of understanding, with sequences available to make molecular probes for virtually all IGFBP (for reviews, see Rechler & Brown 1992; Jones & Clemmons, 1995) . However, no work has been published on the IGFBP genes in pigs.
Insulin-like growth factor receptors
The actions of the IGF are mediated via two independent receptors (for review, see Jones & Clemmons, 1995) . The type-1 IGF-receptor (IGF-1R) is structurally similar to the insulin receptor and indeed binds insulin with a low affinity. The comparative binding of the three ligands to IGF-1R is IGF-I > IGF-I1 % insulin and, therefore, supraphysiological concentrations of insulin are able to exert IGF actions via the IGF-1R. The second receptor, the IGF-2R, has been shown to be the cation-independent mannose-6-phosphate receptor, and binds IGF-I1 with a greater affinity than IGF-I, and does not bind insulin at all. The elucidation of the second messenger pathways linking ligand binding to the various intracellular actions is still in its infancy. However, the IGF-1R is known to involve a tyrosine kinase activity and receptor phosphorylation, whereas the IGF-2R is reported to couple to a GTP-binding protein. There is a lack of published work on the regulation of IGF-receptor levels (protein or mRNA) in the pig, despite their obvious importance in the control of growth and metabolism. The studies carried out to date on the IGF-1R are in rats (Dardevet et al. 1991) or sheep (Glassford et al. 1995; Oldham et al. 1996) , and all seem to indicate the major regulator of IGF-1R to be IGF-I itself. Any condition that results in decreased IGF-I concentrations (e.g. fasting, feed restriction or diabetes) results in increased IGF-1R expression (for review, see Werner et al. 1995).
WHOLE-ANIMAL PIG STUDIES
A number of groups have studied the effects of dietary manipulation and/or GH administration on pig growth, but few have tried to identify the mechanisms involved. The present review will look at the effects of diet and/or GH on the various components of the GH-IGF system, at both the gene and protein levels, and in particular at IGF-I, which is thought to be the main growth factor responsible for the changes in growth rate.
Effects of manipulating energy availability
Recent studies have demonstrated effects on growth and expression of GHR and IGF-I genes with increasing energy availability via intake and environmental temperature in young growing pigs Weller et al. 1994) . GHR expression in the liver was found to increase with food intake, whereas expression in longissimus dorsi (LD) muscle decreased with increased food intake and temperature . Strong positive correlations were observed between liver GHR mRNA and both plasma IGF-I concentration and growth rate, whereas a negative correlation was noted between LD muscle GHR mRNA and growth rate. Thus, the effects of intake and temperature on growth rate appeared to be mediated via control of liver GHR expression. However, it should be noted that plasma triiodothyronine (T3) concentrations were affected by these manipulations, and that liver GHR mRNA and plasma T3 concentrations were also positively correlated. Thus, whether the dietary effects observed are direct nutrient effects on gene expression, or indirect via T3 remains to be answered.
A similar study was also carried out to study the effects of energy availability on IGF-I expression (Weller et al. 1994) . The results were similar to the effects on GHR expression, in that expression in the liver increased with both intake and temperature, whereas expression in LD muscle decreased with increased intake and temperature. It was. also found that major levels of class 2 transcripts (exon 2-containing transcripts) of IGF-I were only present in the liver, a result also found in other whole-animal pig studies looking at differences with age (Brameld et al. 1995a ) and breed of pig (Brameld et al. 1996~) . Increased growth rates were accompanied by an increase in the proportion of class 2 IGF-I mRNA in the liver, suggesting a role for class 2 IGF-I in the endocrine growth response. It had previously been demonstrated that these dietary and temperature manipulations had no marked effects on circulating GH concentrations (Dauncey & Buttle, 1990) , but that there were significant effects on plasma concentrations of IGF-I (Dauncey et al. 1990 ), IGFBP-3 and IGFBP-2 , with both IGF-I and IGFBP-3 increasing with intake and temperature, whereas IGFBP-2 tended to decrease.
These results could all be explained by the hypothesis that dietary energy increases liver GHR expression, thereby increasing the ability of the liver to respond to the circulating GH. However, this hypothesis cannot be tested employing in vivo studies and, therefore, requires further study using in vitro cell culture methods.
Effects of exogenous growth hormone
A number of studies have been carried out to investigate the effects of GH administration on various components of the GH-IGF axis in pigs. Chronic administration of GH to pigs has been shown to increase GH binding to liver membranes (Chung & Etherton, 1986; Ambler et al. 1992) , but not to adipose tissue membranes (Sorensen et al. 1992) , and to increase GHBP levels in pig serum, with the two being positively correlated (Ambler et al. 1992) , suggesting that serum GHBP levels may reflect hepatic GHR numbers. We (Brameld et al. 19966 ) have subsequently demonstrated GH-dependent increases in expression of both intra-and extracellular domains of the GHR in liver and skeletal muscle (both LD and semitendinosus), but not in adipose tissue (subcutaneous, omental or perirenal).
Exogenous GH has been shown to significantly increase plasma IGF-I concentrations in well-fed animals (Evock et al. 1990; Owens et al. 1990) , and to either decrease (Owens et al. 1990) or have no effect on plasma IGF-I1 (Evock et al. 1990 ). Administration of GH to pregnant sows has also been shown to result in increased plasma IGF-I concentrations in their neonatal offspring (20 kg), but this effect is lost by the time the offspring reach market weight (Kelley et al. 1995) . At the gene level, administration of GH has been shown to result in dose-dependent increases in IGF-I expression in both liver and subcutaneous adipose tissue, but not in LD muscle (Coleman et al. 1994) . Studies at Nottingham (Brameld et al. 19966) have similarly demonstrated GH-dependent increases in class 1 transcripts of IGF-I in liver, all three adipose tissue depots, and also in semitendinosus muscle, but not in LD muscle. Class 2 transcripts of IGF-I were only found in the livers of GH-treated pigs. Time-dependent increases in IGF-I mRNA have been shown as a result of a single GH injection in liver and subcutaneous and perirenal adipose tissues, with a slight increase also being seen in vastus luteratis muscle, but no effect in LD or semitendinosus muscles (Ramsay et al. 1995) . Thus, different muscles appear to respond differently. GH has also been shown to decrease IGF-I1 expression in subcutaneous adipose tissue, and this effect was lessened by feeding an extra 1OOg fatkg diet (Wolverton et al. 1992) . The addition of dietary fat was shown to have no effect on the GH-stimulation of IGF-I expression in the same tissue.
As well as increasing circulating IGF-I concentrations, GH administration has been shown to increase IGFBP-3 and to decrease IGFBP-2 concentrations in serum . The GH effects on IGFBP-2, however, appear to be dependent on dietary protein levels (Guan et al. 1997; see p. 612) , with IGFBP-1 and -4 also being increased by GH (Guan et al. 1997) .
Thus, GH affects many of the components of the GH-IGF axis, not just IGF-I expression and production.
Effects of manipulating dietary protein intake and growth hormone status
Studies of the interaction between dietary protein intake and exogenous GH administration on plasma IGF-I concentrations in pigs have shown contrasting results, with increased protein shown to increase the response of plasma IGF-I to GH Caperna et al. 1990 ), or to have no effect on the GH response (Seve et al. 1993; Brameld et al. 1996b) . However, the differences in dietary protein content in these studies were not restrictive (ranging from 83 to 270 g k g diet), unlike many of the studies carried out in rats, where crude protein (N x 6.25) levels as low as 55g/kg have been used (Dardevet et al. 1991) . The lack of effect of increasing dietary protein on GH-dependent increases in plasma IGF-I concentration was accompanied by a lack of effect on IGF-I expression (both class 1 and 2 transcripts) in pig liver (Grant et al. 1991; Brameld et al. 1996b) . Increasing dietary protein intake (from 99 to 194 gkg, however, was found to significantly increase class 1 transcripts of IGF-I in all three adipose tissue depots, and also to a smaller degree in semitendinosus muscle (Brameld et al. 1996b ), but not in LD muscle (Grant et al. 1991; Brameld et al. 1996b) . A significant positive interaction between dietary protein content and GH administration was observed on IGF-I expression in the adipose tissue depots (Brameld et al. 1996b) .
Similar interactions were also observed on expression of GHR in liver, skeletal muscle and adipose tissue (Brameld et al. 1996b) . However, the direction of the interaction was tissue specific, resulting in the highest level of GHR mRNA being in the high-protein-GHtreated group for liver, but in the low-protein-GH-treated group for muscle (LD and semitendinosus) and adipose tissue (subcutaneous, omental and perirenal).
Recent work at Nottingham has looked at the effects of dietary protein content and GH administration on the circulating IGFBP (Guan et al. 1997) . IGFBP-3 and -1 were both increased at high dietary protein intake, but the dietary protein intake did not interact with the stimulatoiy effects of exogenous GH. The effect of exogenous GH on IGFBP-2 appears to be inhibited by increasing dietary protein intake, such that GH increased IGFBP-2 levels in the pigs fed on the lower-protein diets, but decreased IGFBP-2 levels in the pigs fed on the highest-protein diet (194 gkg). However, these effects were not statistically significant. reported that GH administration decreased plasma IGFBP-2 levels, but they do not state what diet the pigs were fed. It might be expected that a highnutrient (both energy and protein) diet would be given in order to meet the extra demands for growth.
Thus, dietary protein seems to affect both GHR and IGF-I expression, often in tissuespecific ways, as well as altering the circulating IGFBP levels, but further study is required using in vitro cell culture methods to identify whether these are direct nutrient effects on gene expression or indirect via manipulation of hormonal status.
HEPATOCYTE CELL CULTURE STUDIES
It can be seen that the whole-animal studies demonstrate effects of both dietary energy and protein on various components of the GH-IGF system in pigs, with some effects being seen at the mRNA level. However, the true mechanism for these nutrient and hormone effects cannot be determined in vivo, since the dietary manipulations also affect various circulating hormone levels, including GH, insulin, thyroid hormones and glucocorticoids. Thus, it is impossible to identify whether there are direct nutrient-gene interactions, or whether the observed effects are indirect via these circulating hormones.
The liver is the major site of IGF-I expression and production and, more specifically, the parenchymal cells (hepatocytes) are the main cellular site for expression of both GHR and IGF-I (van Neste et al. 1988; Uchijima et al. 1995) . The liver is also a sensor of nutritional and metabolic status and, therefore, a primary site for nutrient-gene interactions. For these reasons we have established a primary pig hepatocyte culture system (Brameld et al. 1995b) , in order to investigate the direct effects of various hormones and nutrients on the expression of GHR and IGF-I genes. For these studies it was essential to use a serum-free culture medium, and to identify which factors were necessary for maintenance of cell viability, in order to reduce the components of the basal medium to a minimum. Very little work in this area has been carried out using pig hepatocytes, with the majority of investigators using rat or chicken hepatocytes. It will be necessary, therefore, to widen the scope for the present discussion to include those species.
Hormonal effects on hepatocyte expression and production
We have demonstrated stimulatory effects of dexamethasone (Dex; a synthetic glucocorticoid) and both thyroid hormones (T3 and thyroxine (T4)) on GHR expression, and also of Dex on IGF-I expression by pig hepatocytes, with T4 appearing to decrease IGF-I expression (Brameld et al. 19956) . When each of these hormones was added in combination with GH, there was significant enhancement of the increases in class 1 transcripts obtained with GH alone, and the appearance of class 2 transcripts of IGF-I, presumably due to an increased number of GHR. Similar increases in class 1 transcripts, and the appearance of class 2 transcripts, were observed in the livers of GH-treated pigs (see p. 61 1). Studies in rat hepatocytes have produced similar effects of Dex on GH binding , 1991) . However, the pig hepatocytes died during prolonged culture without insulin, therefore insulin was always present in the cultures, and indeed appears to be the only essential hormone. The effect of insulin on pig hepatocyte IGF-I and/or GHR expression is, therefore, still unclear, especially as insulin has been shown to be essential for maintenance of protein synthesis and to increase both total and poly(A)+ RNA levels in rat hepatocytes (Hsu et al. 1992) .
Glucagon has been shown to either inhibit IGF-I production, including GH-stimulated production and/or expression (Arany et al. 1993; Denver & Nicoll, 1994) , or to stimulate IGF-I expression and production, with an additive effect when in combination with GH (Kachra et al. 1991) .
Last, epidermal growth factor (EGF) has been shown to increase IGF-I production in a dose-dependent manner (Barreca et al. 1992) , which may be important in the process of liver regeneration after extensive organ mass loss.
Hepatocytes have been shown to secrete mainly IGFBP-1 and -4, but not IGFBP-3, which is only expressed in the non-parenchymal cells (Uchijima et al. 1995) , with the various hormones described previously controlling their secretion into the culture medium. Culture medium concentrations of IGFBP-1 have been shown to be increased by Dex (Miura et al. 1992; Arany et al. 1993; Uchijima et al. 1995) , glucagon (Kachra et al. 1991; Denver & Nicoll, 1994; Uchijima et al. 1995) and EGF (Barreca et al. 1992) , and to be decreased by insulin (Miura et al. 1992; Arany et al. 1993; Denver & Nicoll, 1994; Uchijima et al. 1995) , with T3 shown to have no effect (Uchijima et al. 1995) and GH to either have no effect (Uchijima et al. 1995) , or to decrease secretion (Kachra et al. 1991 ; Miura et al. 1992; Thissen et al. 1994) . IGFBP-4 secretion was found to be increased by Dex (Arany et al. 1993) , T3 (Uchijima et al. 1995) , insulin (Uchijima et al. 1995) and glucagon (Kachra et al. 1991; Uchijima et al. 1995) , and to be decreased by GH (Kachra et al. 1991) .
Effects of glucose on hepatocyte expression and production
The major energy source in non-ruminants is glucose, and glucose has been shown to inhibit the gradual decline in GH binding to rat hepatocytes seen when they are cultured in serum-free conditions (Niimi et al. 1991) . A similar effect was observed in pig hepatocytes (Brameld et al. 1995b) , with high glucose levels reducing the decline in GHR expression with time in culture. Recent work has involved investigating the effects of glucose on GHR expression by pig hepatocytes, and we have demonstrated dose-dependent increases in GHR expression with increased glucose concentration both in the presence and absence of T3 and Dex (Brameld, unpublished results) , but only following an initial overnight preincubation without glucose, in order to deplete the hepatocytes of their stored glucose. A lack of glucose was found to be dominant over the added hormones, in that the stimulatory effect of T3 and Dex was only seen in the presence of high concentrations of glucose, or in cells that had not been depleted of glucose. Whether glucose has any effect on IGF-I expression by the pig hepatocytes remains to be seen, but increased glucose has been found either to have no effect (Arany et al. 1993) , or to increase (Luo & MacRae, 1990) IGF-I production by rat hepatocytes.
The only published study on the effects of glucose on IGFBP expression andor secretion by rat hepatocytes (Arany et al. 1993) shows a decrease in IGFBP-1 mRNA with increased glucose, but no effect on secretion. There was, however, an interaction between glucose and insulin on IGFBP-1 secretion, such that as the glucose concentration increased so insulin became less effective in reducing IGFBP-1 secretion. Thus, at lower (2.7 and 6.5 mM) glucose concentrations, insulin reduced IGFBP-1 levels in a dose-dependent manner; but, at higher (1 1-1 m~) glucose concentrations, insulin had no effect on IGFBP-1 levels.
Direct stimulatory effects of glucose, or one of its metabolites, on hepatocyte gene expression have previously been described for a number of genes, including fatty acid synthase (EC 2.3.1.85; FAS; Prip-Buus et al. 1995), liver pyruvate kinase (EC 2.7.1.40; LPK; Kang et al. 1996) , SI4 (Jacoby et al. 1989) , and glucose transporter type 2 (GLUT 2; Rencurel et al. 1996) , with glucose also being shown to directly stimulate expression of insulin mRNA by p-cells in the pancreas (for review, see Docherty & Clark, 1994). Many of these genes also seem to be dependent on the presence of insulin (FAS, Prip-Buus et al.
1995; LPK, Kang et al. 1996) , and to some extent T3 and Dex (Prip-Buus et al. 1995), all of which have some effect on pig GHR expression (see p. 613). DNA-binding studies and transfection of suspected gene promoter constructs have revealed glucose response elements (GlRE; for review, see Vaulont & Kahn, 1994) , which have a consensus sequence of CACGGG or CACGTG. Whether the pig GHR gene has a similar GlRE in one of its promoters remains to be seen, since the actual number and sequence(s) of GHR promoters in any species remains to be established.
Effects of amino acids on hepatocyte expression and production
No studies of the effects of altering culture medium amino acid concentrations on pig hepatocyte expression or production of GH-IGF components have been reported to date. However, effects of altering the concentrations of total amino acids in rat hepatocyte culture medium have been studied. Conflicting results have been published on the effects of increasing amino acids on the expression and production of IGF-I and IGFBP-1. Two studies have shown increases in IGF-I mRNA (Phillips et al. 1991; Thissen et al. 1994) and decreases in IGFBP-1 mRNA and production with increased amino acids (Thissen et al. 1994) , but another study showed the opposite, with decreases in IGF-I secretion and increases in IGFBP-1 mRNA and production with increased amino acids (Arany et al. 1993) . The most recent study (Thissen et al. 1994 ) also demonstrated interactions between the amino acid concentrations and GH on both IGF-I and IGFBP-1 expression, such that the stimulatory effects of GH on IGF-I expression were enhanced in the presence of the highest amino acid concentrations, whereas the inhibitory effects of GH on IGFBP-1 expression were diminished in the presence of the highest amino acid concentrations. Studies carried out using rat hepatoma cells (a liver-derived cell line) have demonstrated increases in IGFBP-1 mRNA following removal of a single essential amino acid (phenylalanine, methionine, leucine, or tryptophan) from the serum-free culture medium for 24 h (Straus et al. 1993) .
The current understanding of amino acid-dependent control of gene expression in mammalian cells is very limited, although the evidence suggests that deprivation of one or a number of amino acids leads to an increase in the expression and production of a putative regulatory protein, which in turn alters target gene expression (for review, see Kilberg et al. 1994) . However, the identification of this (or these) regulatory proteins is at a very early stage.
CONCLUSIONS
The molecular mechanisms by which nutrients and hormones interact to control expression of the genes for the various components of the porcine GH-IGF system and, therefore, growth are likely to be very complex. Both the energy component and the protein (amino acid) component of the diet appear to directly control gene expression, in combination with various endocrine hormones also regulated by the diet. No single component of the GH-IGF system is likely to be dominant over the rest and, therefore, it is the overall effect on IGF bioactivity that is important. The energy component (glucose) would appear to be the major regulator of GHR expression, with various hormones also interacting. The protein component (amino acids) has been postulated to directly affect IGF-I expression, but this would appear to be dependent on the GH status of the animal. However, GH is the only factor that has been shown to directly increase the rate of transcription of IGF-I. The functions of the IGFBP are still not clear, but they are also affected, be that directly or indirectly, by diet. The primary regulator of the IGF-1R appears to be IGF-I itself; however, further study of nutrient effects is obviously necessary. Thus, the mechanisms relating to nutrient control of gene expression are still unclear, but there is increasing evidence for direct interactions of nutrients in the control of expression of various growth regulatory genes.
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